Skip to content
ProvidersDesk
Q0235

Inj, monoclon antibody, 1 mg

✓ CURRENT — JULY 2026
Source: CMS
Imported: Aug 10 2026

Full descriptor

Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg

Details

Code
Q0235
Short descriptor
Inj, monoclon antibody, 1 mg
Code set
HCPCS Level II
Release
July 2026
Status
Active
Added
Oct 1 2025

Nearby codes

Code sets are published in blocks, so neighbours are usually related.

Q0234

Inj, tocilizumab-bavi, 1mg

Q0237

Inj, tocilizumab-anoh, hospi

Q0238

Inj, tocilizumab-aazg, hospi

Q0224

Inj, pemivibart, 4500 mg

Q0249

Tocilizumab for covid-19

Q0181

Unspecified oral anti-emetic

Q0180

Dolasetron mesylate oral

Q0177

Hydroxyzine pamoate 25mg

Sources

Reference information only. Not billing advice. Verify against the payer before you file.